Detalles de la búsqueda
1.
Preferences for different treatment options among people living with acromegaly in the US.
Curr Med Res Opin;
40(4): 657-664, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38317571
2.
Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification.
Nat Rev Endocrinol;
19(11): 671-678, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37592077
3.
Towards an Earlier Diagnosis of Acromegaly and Gigantism.
J Clin Med;
10(7)2021 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33810319
4.
Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practice.
BMC Endocr Disord;
20(1): 117, 2020 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32736547
5.
An evaluation of the Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ) in adult patients with acromegaly, including correlations with other patient-reported outcome measures: data from two large multicenter international studies.
Pituitary;
23(4): 347-358, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32221764
6.
Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider.
Pituitary;
23(2): 140-148, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31808101
7.
ACRODAT® and AcroVoice: an insight into a holistic approach to the management of acromegaly.
Pituitary;
22(6): 647-648, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31598813
8.
Development of a novel patient-reported measure for acromegaly: the Acro-TSQ.
Pituitary;
22(6): 581-593, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31522359
Resultados
1 -
8
de 8
1
Próxima >
>>